Abstract
Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain Metastases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have